A Beacon of Light on Your Cancer Care Journey

EASTERN CONNECTICUT HEMATOLOGY & ONCOLOGY ASSOCIATES

Who can benefit from the booster

Currently, CDC is recommending that moderately to severely immunocompromised people receive an additional dose. This includes people who have:

  • Active treatment for solid tumor and hematologic malignancies
  • Receipt of solid-organ transplant and taking immunosuppressive therapy
  • Receipt of CAR-T-cell or hematopoietic stem cell transplant (within 2 years of transplantation or taking immunosuppression therapy)
  • Moderate or severe primary immunodeficiency (e.g., DiGeorge syndrome, Wiskott-Aldrich syndrome)
  • Advanced or untreated HIV infection
  • Active treatment with high-dose corticosteroids (i.e., ≥20mg prednisone or equivalent per day), alkylating agents, antimetabolites, transplant-related immunosuppressive drugs, cancer chemotherapeutic agents classified as severely immunosuppressive, tumor-necrosis (TNF) blockers, and other biologic agents that are immunosuppressive or immunomodulatory.

Patients can contact the place where they received their first vaccine or can check with local pharmacies or clinics. The recommendation is to stay with the same vaccine (i.e. Modern or Pfizer) you originally received.


We will share additional information on this topic once it is available.